Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, November 29, 2014
Very on Point Comment from Reader on Issues Facing State Boards of Pharmacies
Question of the Day November 27, 2014 What is the biggest issue in the compounding industry today that is being overlooked by state boards of pharmacies? How would the compounding pharmacy world improve if the state boards of pharmacy would address the issues relating to traditional compounding?
California State Board of Pharmacy Permanently Revokes One Pharmacist’s License and His Pharmacy’s Permit
by David W. Hodge
The California State Board of Pharmacy has acted as a stern example for pharmacists and pharmacies across the Golden State, and the Fourth Appellate District court agrees with the Board’s decision.
Pharmacist Tue Hoang was in charge of Orange Pharmacy when the pharmacy refused an on-site fraud prevention review. The review was mandatory for pharmacies that wanted to submit claims for certain prescriptions under Medi-Cal, so Orange was excluded from the program.
Hoang was not thwarted for long, however, as he cooked up the scheme that would eventually land him in hot water with the Board. Hoang arranged for Orange Pharmacy to dispense Medi-Cal prescriptions, but would forward the information to another local pharmacy, Pacific Pharmacy. Pacific would then submit the claims as their own, and would return the payments to Orange.
When the California State Board of Pharmacy learned of the arrangement, Hoang was brought before an administrative law judge (ALJ), who recommended that Hoang’s pharmacist license and Orange Pharmacy’s permits essentially be placed on probation for five years. The Board opted to ignore the judge’s recommendation, and instead opted to permanently revoke Orange Pharmacy’s permit and Hoang’s license.
continue to read here
Question of the Day November 29, 2014 Why hasn't or doesn't physicans/doctors object to pharmacists crossing over into the "practice of medicine" especially with the surveys and questionaires and advising patients that they need compounded medications, when in fact they may need no medication at all?
Utah Board of Pharmacy Audio and Handouts Available for the November 18, 2014 Meeting (disciplinary action against compounding pharmacies, compounding task force report and rule changes)
Pharmacy_2014-11-18_Audio pt 3.mp3Audio RecordingAdded: 2014/11/19 09:50 AMPharmacy_2014-11-18_Audio pt 1.mp3Audio RecordingAdded: 2014/11/19 09:50 AMPharmacy_2014-11-18_Audio pt 2.mp3Audio RecordingAdded: 2014/11/19 09:50 AMPharmacy_2014-11-18_handouts pt 1.pdfPublic Information HandoutAdded: 2014/11/19 09:50 AMPharmacy_2014-11-18_agenda update 2.pdfOtherAdded: 2014/11/14 11:19 AMPharmacy_2014-11-18_agenda.pdfOtherAdded: 2014/11/06 12:05 PMPharmacy_2014-11-18_agenda.pdfOtherAdded: 2014/11/12 09:39 AM |
Arizonia Board of Pharmacy October 2014 Meeting Minutes and Video Now Available
The minutes and video from the October board meeting are now available.
Subscribe to:
Posts (Atom)
1 comment:
**Chemicals are recipes are SOLD for compounding but not warrantied for this use
**Boards need to to acknowledge financial incentives and conflicts of interest for recommending substitution of compounded drugs at individual and population levels under the guise of pharmacy professionalism (steering patients to compounds in lieu of regulated finished products to make more money)
**While boards are exceptionally well qualified and suited to regulate the licensing and professional practice of pharmacists and doctors, they are not well suited to regulating the safety, effectiveness and security of drug supplies
**There are no surveillance procedures for safety, quality, adverse event reporting and counterfeiting/bioterrorism chemical security for most states
**Pharmaceutical Care Models are useful at state levels for determining if and when a patient cannot be treated with an FDA-approved product, which carry product liability insurance, and what disclosures should be made regarding financial interests surrounding recommendations
**Having the often-claimed "right" to compound medications does not mean you should
**Compounded drugs may be compulsory for patients in certain settings (they are used based on contracts with health clinics, nursing homes) are a breach of professionalism and unethical if patients or their caregivers are not given an option to chose an FDA-approved, GMP-produced formulation